The Corealis leadership team consists of professionals with extensive scientific and service industry expertise. Their seasoned careers provide the experience to tackle the most intricate challenges faced by clients.
Yves Roy, Ph.D. – President
Dr. Roy holds a doctorate in toxicology from the Université Catholique de Louvain. He also has Bachelor of Science and Master of Science degrees in biology from the Université du Québec à Montréal.
Dr. Roy’s early career includes several high-profile management positions in major pharma companies. In 1999, he moved into business development for both startups and established companies. To support R&D, he introduced new services and emerging technologies. In his role, Dr. Roy has dealt with the many challenges that pharmaceutical startups face.
Dr. Roy’s experience in management and knowledge of the industry is an asset to Corealis.
Patrick Gosselin, Ph.D. – Vice-President — Pharmaceutical R&D
Dr. Gosselin handles the drug product formulation and process development of new chemical entities. He also oversees Phase I, II and early Phase III clinical trial material manufacturing. He has a bachelor’s degree in chemical engineering and a doctorate in pharmaceutical technology, both awarded by the Université de Montréal.
Dr. Gosselin has a background in pharma development. He worked for several major companies in a variety of roles, such as R&D project leader for the German company ratiopharm international. While at ratiopharm, he contributed to the development of a range of products and helped establish a center of excellence in R&D.
Dr. Gosselin is an associate professor at the Université du Québec à Montréal. He has published an array of material, including peer-reviewed publications and patents.
Yves Mouget, Ph.D. – Vice-President — Analytics
Dr. Mouget holds a Bachelor of Science degree from Concordia University and a doctorate from the Université de Montréal. On graduating, he joined MDS Sciex as a research and application chemist. There, he developed his understanding of R&D work in the pharmaceutical environment.
In 2000, Dr. Mouget accepted the position of R&D Director at Pharmalaser. His knowledge and experience of the sector deepened, leading to more career progression. In 2003, he joined ratiopharm as Director of Analytical Development. This move placed Yves at the heart of the pharmaceutical development process.
During the course of his career, Dr. Mouget has collaborated with research centers the world over. He has presented and published several respected papers. He appreciates addressing the multifaceted challenges faced by clients in bringing pharmaceutical products to the market.
Corealis’ experts are ready to answer any queries about the company’s oral solid dose offering, including its development and manufacturing capabilities.